MMR

Brief about this service

MMR testing supports interpretation relevant to tumor biology and downstream clinical discussions.

Mismatch repair marker assessment in appropriate oncology workflows. Each case is processed under quality-controlled oncology diagnostics workflows for clinically meaningful output.

When this test is commonly used

• Tumors where mismatch repair pathway assessment supports case interpretation.
• Cases where clinicians need marker-based biological context in reports.
• Oncology pathways where downstream management discussions depend on MMR status.

Sample and reporting guidance

Provide representative tissue sections or blocks with relevant histology context so marker interpretation can be correlated accurately with morphology.

Reports are structured for doctor readability with concise interpretation notes and pathway-oriented communication.